» Articles » PMID: 30402112

Mesenchymal Stem Cell Therapy for Ischemic Tissues

Overview
Journal Stem Cells Int
Publisher Wiley
Specialty Cell Biology
Date 2018 Nov 8
PMID 30402112
Citations 37
Authors
Affiliations
Soon will be listed here.
Abstract

Ischemic diseases such as myocardial infarction, ischemic stroke, and critical limb ischemia are immense public health challenges. Current pharmacotherapy and surgical approaches are insufficient to completely heal ischemic diseases and are associated with a considerable risk of adverse effects. Alternatively, human mesenchymal stem cells (hMSCs) have been shown to exhibit immunomodulation, angiogenesis, and paracrine secretion of bioactive factors that can attenuate inflammation and promote tissue regeneration, making them a promising cell source for ischemic disease therapy. This review summarizes the pathogenesis of ischemic diseases, discusses the potential therapeutic effects and mechanisms of hMSCs for these diseases, and provides an overview of challenges of using hMSCs clinically for treating ischemic diseases.

Citing Articles

Alginate-Encapsulated Mesenchymal Stromal Cells Improve Hind Limb Ischemia in a Translational Swine Model.

Deppen J, Ginn S, Tang E, Wang L, Brockman M, Levit R J Am Heart Assoc. 2024; 13(9):e029880.

PMID: 38639336 PMC: 11179867. DOI: 10.1161/JAHA.123.029880.


Role and mechanism of miRNA in cardiac microvascular endothelial cells in cardiovascular diseases.

Yan J, Zhong X, Zhao Y, Wang X Front Cardiovasc Med. 2024; 11:1356152.

PMID: 38545341 PMC: 10966125. DOI: 10.3389/fcvm.2024.1356152.


Optical and MRI Multimodal Tracing of Stem Cells In Vivo.

Yang J, Yan M, Wang Z, Zhang C, Guan M, Sun Z Mol Imaging. 2023; 2023:4223485.

PMID: 38148836 PMC: 10751174. DOI: 10.1155/2023/4223485.


Co-Delivery of Bioengineered Exosomes and Oxygen for Treating Critical Limb Ischemia in Diabetic Mice.

Zhong T, Gao N, Guan Y, Liu Z, Guan J ACS Nano. 2023; 17(24):25157-25174.

PMID: 38063490 PMC: 10790628. DOI: 10.1021/acsnano.3c08088.


Local transplantation of mesenchymal stem cells improves encephalo-myo-synangiosis-mediated collateral neovascularization in chronic brain ischemia.

Zhang X, Huang Y, Liu Y, Liu Y, He X, Ma X Stem Cell Res Ther. 2023; 14(1):233.

PMID: 37667370 PMC: 10478472. DOI: 10.1186/s13287-023-03465-7.


References
1.
Perea-Gil I, Monguio-Tortajada M, Galvez-Monton C, Bayes-Genis A, Borras F, Roura S . Preclinical evaluation of the immunomodulatory properties of cardiac adipose tissue progenitor cells using umbilical cord blood mesenchymal stem cells: a direct comparative study. Biomed Res Int. 2015; 2015:439808. PMC: 4377370. DOI: 10.1155/2015/439808. View

2.
Bago J, Soler-Botija C, Casani L, Aguilar E, Alieva M, Rubio N . Bioluminescence imaging of cardiomyogenic and vascular differentiation of cardiac and subcutaneous adipose tissue-derived progenitor cells in fibrin patches in a myocardium infarct model. Int J Cardiol. 2013; 169(4):288-95. DOI: 10.1016/j.ijcard.2013.09.013. View

3.
Rehman J, Traktuev D, Li J, Merfeld-Clauss S, Temm-Grove C, Bovenkerk J . Secretion of angiogenic and antiapoptotic factors by human adipose stromal cells. Circulation. 2004; 109(10):1292-8. DOI: 10.1161/01.CIR.0000121425.42966.F1. View

4.
Kim Y, Kim H, Cho H, Bae Y, Suh K, Jung J . Direct comparison of human mesenchymal stem cells derived from adipose tissues and bone marrow in mediating neovascularization in response to vascular ischemia. Cell Physiol Biochem. 2007; 20(6):867-76. DOI: 10.1159/000110447. View

5.
Bayes-Genis A, Soler-Botija C, Farre J, Sepulveda P, Raya A, Roura S . Human progenitor cells derived from cardiac adipose tissue ameliorate myocardial infarction in rodents. J Mol Cell Cardiol. 2010; 49(5):771-80. DOI: 10.1016/j.yjmcc.2010.08.010. View